2003
DOI: 10.1002/chin.200317181
|View full text |Cite
|
Sign up to set email alerts
|

New Cholinesterase Inhibiting Steroidal Alkaloids from the Leaves of Sarcococca coriacea of Nepalese Origin.

Abstract: Alkaloids Alkaloids U 0600New Cholinesterase Inhibiting Steroidal Alkaloids from the Leaves of Sarcococca coriacea of Nepalese Origin. -From the dried aerial parts of the title plant the two novel compounds (I) and (II) together with two known substances are isolated from the methanol extract. -(KALAUNI, S. K.; CHOUDHARY*, M. I.; KHALID, A.; MANANDHAR, M. D.; SHAHEEN, F.; ATTA-UR-RAHMAN; GEWALI, M. B.; Chem.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1

Citation Types

0
20
0

Year Published

2004
2004
2015
2015

Publication Types

Select...
7
1

Relationship

1
7

Authors

Journals

citations
Cited by 14 publications
(20 citation statements)
references
References 1 publication
0
20
0
Order By: Relevance
“…AChE inhibitors are the most effective approach to treat the cognitive symptoms of Alzheimer disease (AD) (Kalauni et al 2002) and other possible therapeutic applications in the treatment of Parkinson's disease, senile dementia, and ataxia, among others (Ahmad et al 2003a). AChE inhibitors as eserine, tacrine, donepezil, rivastigmine, and galanthamine are the only drugs currently approved for the treatment of AD; however, these drugs are known to have limitations for clinical use due to their short-half-lives and/or unfavorable side-effects (Sung et al 2002).…”
mentioning
confidence: 99%
“…AChE inhibitors are the most effective approach to treat the cognitive symptoms of Alzheimer disease (AD) (Kalauni et al 2002) and other possible therapeutic applications in the treatment of Parkinson's disease, senile dementia, and ataxia, among others (Ahmad et al 2003a). AChE inhibitors as eserine, tacrine, donepezil, rivastigmine, and galanthamine are the only drugs currently approved for the treatment of AD; however, these drugs are known to have limitations for clinical use due to their short-half-lives and/or unfavorable side-effects (Sung et al 2002).…”
mentioning
confidence: 99%
“…The activities of AChE sometimes lead to several neurological disorders such as Alzheimer's disease, senile dementia, and ataxia (Kalauni et al, 2002). The AChE inhibitory activity of methanol, and hot water extracts from R. rosacea fruiting bodies were investigated.…”
Section: Anti-acetylcholinesterase Activitymentioning
confidence: 99%
“…AChE inhibitors can increase cholinergic transmission by preventing the hydrolysis of released ACh, thus making more ACh available at the cholinergic synapse (Benzi and Morreti, 1998). This makes AChE inhibitors the most effective means to treat the cognitive symptoms of Alzheimer's disease (Kalauni et al, 2002). AChE inhibitors such as physostigmine, tacrine, donepezil, rivastigmine, and galanthamine are the only currently available drugs for the treatment of AD.…”
Section: Introductionmentioning
confidence: 99%
“…The cholinesterase inhibitory activities, represented by IC 50 (μM), were obtained from recently published data (Atta ur, Choudhary, 2000, Atta ur et al, 2003, Atta ur et al, 1997, Atta ur, Zaheer ul, 2002, Kalauni, Choudhary, 2001 (Table 1). The structures of inhibitors are presented in Table 2.…”
Section: Biological Datamentioning
confidence: 99%
“…The discovery of natural cholinesterase inhibitors has been a very challenging area of drug development due to the involvement of cholinesterases in Alzheimer's disease and other related dementias. We have previously reported a number of new natural inhibitors of cholinesterases (AChE and BuChE) isolated from indigenous medicinal plants (Atta ur et al, 2000, Atta ur et al, 2002, Kalauni et al, 2001. The steady state inhibition kinetics, pharmacological profiles, SAR and molecular docking studies have been conducted on a similar series of compounds for AChE inhibition , Zaheer-Ul-Haq et al, 2003.…”
mentioning
confidence: 99%